|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
multiple interactions increases expression decreases response to substance decreases expression decreases activity |
ISO EXP |
abamectin inhibits the reaction [ABCB1 protein results in increased transport of bisbenzimide ethoxide trihydrochloride] abamectin results in increased expression of ABCB1A mRNA [Ascorbic Acid co-treated with Sesame Oil] inhibits the reaction [abamectin results in increased expression of ABCB1A mRNA]; Ascorbic Acid inhibits the reaction [abamectin results in increased expression of ABCB1A mRNA]; Sesame Oil inhibits the reaction [abamectin results in increased expression of ABCB1A mRNA] ABCB1A protein results in decreased susceptibility to abamectin abamectin results in decreased expression of ABCB1A protein abamectin results in decreased activity of ABCB1A protein abamectin inhibits the reaction [ABCB1A protein results in increased transport of bisbenzimide ethoxide trihydrochloride] abamectin results in decreased activity of ABCB1 protein |
CTD |
PMID:9144452 PMID:17134887 PMID:19879343 PMID:25865432 PMID:31739238 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
multiple interactions decreases activity |
ISO |
abamectin inhibits the reaction [ABCC1 protein results in increased transport of bisbenzimide ethoxide trihydrochloride] abamectin results in decreased activity of ABCC1 protein |
CTD |
PMID:25865432 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Actb |
actin, beta |
decreases expression |
ISO |
abamectin results in decreased expression of ACTB protein |
CTD |
PMID:19879343 |
|
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
|
|
G |
Akt1 |
AKT serine/threonine kinase 1 |
decreases expression |
ISO |
abamectin results in decreased expression of AKT1 protein |
CTD |
PMID:30958899 |
|
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
|
|
G |
Ano1 |
anoctamin 1 |
decreases activity |
ISO |
abamectin results in decreased activity of ANO1 protein |
CTD |
PMID:32201246 |
|
NCBI chr 1:199,751,439...199,900,099
Ensembl chr 1:199,751,439...199,900,069
|
|
G |
Atf6 |
activating transcription factor 6 |
multiple interactions increases expression |
EXP |
Hesperidin inhibits the reaction [abamectin results in increased expression of ATF6 mRNA] |
CTD |
PMID:34748272 |
|
NCBI chr13:82,927,579...83,106,381
Ensembl chr13:82,930,034...83,107,177
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
multiple interactions increases expression |
EXP |
Hesperidin inhibits the reaction [abamectin results in increased expression of BAX mRNA]; Hesperidin inhibits the reaction [abamectin results in increased expression of BAX protein] abamectin results in increased expression of BAX mRNA; abamectin results in increased expression of BAX protein |
CTD |
PMID:34748272 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
multiple interactions decreases expression |
EXP |
Hesperidin inhibits the reaction [abamectin results in decreased expression of BCL2 mRNA]; Hesperidin inhibits the reaction [abamectin results in decreased expression of BCL2 protein] abamectin results in decreased expression of BCL2 mRNA; abamectin results in decreased expression of BCL2 protein |
CTD |
PMID:34748272 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Becn1 |
beclin 1 |
increases expression multiple interactions |
EXP |
abamectin results in increased expression of BECN1 protein Hesperidin inhibits the reaction [abamectin results in increased expression of BECN1 protein] |
CTD |
PMID:34748272 |
|
NCBI chr10:86,231,387...86,246,742
Ensembl chr10:86,231,388...86,246,742
|
|
G |
Casp3 |
caspase 3 |
increases activity increases expression multiple interactions |
ISO EXP |
abamectin results in increased activity of CASP3 protein abamectin results in increased expression of CASP3 mRNA; abamectin results in increased expression of CASP3 protein [Ascorbic Acid co-treated with Sesame Oil] inhibits the reaction [abamectin results in increased expression of CASP3 protein]; Ascorbic Acid inhibits the reaction [abamectin results in increased expression of CASP3 protein]; Hesperidin inhibits the reaction [abamectin results in increased expression of CASP3 mRNA]; Hesperidin inhibits the reaction [abamectin results in increased expression of CASP3 protein]; Sesame Oil inhibits the reaction [abamectin results in increased expression of CASP3 protein] |
CTD |
PMID:30958899 PMID:31739238 PMID:34748272 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cat |
catalase |
multiple interactions decreases activity increases activity |
EXP |
[Ascorbic Acid co-treated with Sesame Oil] inhibits the reaction [abamectin results in increased activity of CAT protein]; Ascorbic Acid inhibits the reaction [abamectin results in increased activity of CAT protein]; Hesperidin inhibits the reaction [abamectin results in decreased activity of CAT protein]; Sesame Oil inhibits the reaction [abamectin results in increased activity of CAT protein] |
CTD |
PMID:31739238 PMID:34748272 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions increases expression |
EXP |
[Ascorbic Acid co-treated with Sesame Oil] inhibits the reaction [abamectin results in increased expression of CYP2E1 protein]; Ascorbic Acid inhibits the reaction [abamectin results in increased expression of CYP2E1 protein]; Sesame Oil inhibits the reaction [abamectin results in increased expression of CYP2E1 protein] |
CTD |
PMID:31739238 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
increases expression multiple interactions |
EXP |
abamectin results in increased expression of EIF2AK3 mRNA Hesperidin inhibits the reaction [abamectin results in increased expression of EIF2AK3 mRNA] |
CTD |
PMID:34748272 |
|
NCBI chr 4:102,805,495...102,866,914
Ensembl chr 4:102,805,510...102,866,911
|
|
G |
Ern1 |
endoplasmic reticulum to nucleus signaling 1 |
increases expression multiple interactions |
EXP |
abamectin results in increased expression of ERN1 mRNA Hesperidin inhibits the reaction [abamectin results in increased expression of ERN1 mRNA] |
CTD |
PMID:34748272 |
|
NCBI chr10:91,326,889...91,421,201
Ensembl chr10:91,330,654...91,421,029
|
|
G |
Hmox1 |
heme oxygenase 1 |
multiple interactions decreases expression |
EXP |
Hesperidin inhibits the reaction [abamectin results in decreased expression of HMOX1 mRNA] |
CTD |
PMID:34748272 |
|
NCBI chr19:13,466,287...13,474,082
Ensembl chr19:13,467,244...13,474,079
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
increases expression multiple interactions |
EXP |
abamectin results in increased expression of HSPA5 mRNA Hesperidin inhibits the reaction [abamectin results in increased expression of HSPA5 mRNA] |
CTD |
PMID:34748272 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Il1b |
interleukin 1 beta |
increases expression multiple interactions |
EXP |
abamectin results in increased expression of IL1B mRNA Hesperidin inhibits the reaction [abamectin results in increased expression of IL1B mRNA] |
CTD |
PMID:34748272 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions increases expression |
EXP |
Hesperidin inhibits the reaction [abamectin results in increased expression of IL6 mRNA] |
CTD |
PMID:34748272 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Jak2 |
Janus kinase 2 |
increases expression multiple interactions |
EXP |
abamectin results in increased expression of JAK2 mRNA Hesperidin inhibits the reaction [abamectin results in increased expression of JAK2 mRNA] |
CTD |
PMID:34748272 |
|
NCBI chr 1:226,995,334...227,054,381
Ensembl chr 1:226,995,334...227,054,189
|
|
G |
Map1lc3a |
microtubule-associated protein 1 light chain 3 alpha |
multiple interactions increases expression |
EXP |
Hesperidin inhibits the reaction [abamectin results in increased expression of MAP1LC3A mRNA] |
CTD |
PMID:34748272 |
|
NCBI chr 3:143,783,024...143,784,670
Ensembl chr 3:143,783,024...143,784,670
|
|
G |
Map1lc3b |
microtubule-associated protein 1 light chain 3 beta |
multiple interactions increases expression |
EXP |
Hesperidin inhibits the reaction [abamectin results in increased expression of MAP1LC3B mRNA] |
CTD |
PMID:34748272 |
|
NCBI chr19:49,665,795...49,673,655
Ensembl chr19:49,665,791...49,677,690
|
|
G |
Mapk14 |
mitogen activated protein kinase 14 |
increases expression multiple interactions |
EXP |
abamectin results in increased expression of MAPK14 mRNA Hesperidin inhibits the reaction [abamectin results in increased expression of MAPK14 mRNA] |
CTD |
PMID:34748272 |
|
NCBI chr20:6,749,646...6,810,590
Ensembl chr20:6,749,670...6,810,589
|
|
G |
Nfe2l2 |
NFE2 like bZIP transcription factor 2 |
multiple interactions decreases expression |
EXP |
Hesperidin inhibits the reaction [abamectin results in decreased expression of NFE2L2 mRNA] |
CTD |
PMID:34748272 |
|
NCBI chr 3:60,594,239...60,621,785
Ensembl chr 3:60,594,242...60,621,737
|
|
G |
Nfkb1 |
nuclear factor kappa B subunit 1 |
increases expression multiple interactions |
EXP |
abamectin results in increased expression of NFKB1 mRNA Hesperidin inhibits the reaction [abamectin results in increased expression of NFKB1 mRNA] |
CTD |
PMID:34748272 |
|
NCBI chr 2:224,016,214...224,132,135
Ensembl chr 2:224,016,214...224,110,404
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
multiple interactions |
ISO |
abamectin inhibits the reaction [Chenodeoxycholic Acid results in increased activity of NR1H4 protein]; abamectin inhibits the reaction [pregna-4,17-diene-3,16-dione results in decreased activity of NR1H4 protein] |
CTD |
PMID:25257666 |
|
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
|
|
G |
Sqstm1 |
sequestosome 1 |
decreases expression |
ISO |
abamectin results in decreased expression of SQSTM1 protein |
CTD |
PMID:30958899 |
|
NCBI chr10:34,525,517...34,536,685
Ensembl chr10:34,525,519...34,536,673
|
|
G |
Stat3 |
signal transducer and activator of transcription 3 |
increases expression multiple interactions |
EXP |
abamectin results in increased expression of STAT3 mRNA Hesperidin inhibits the reaction [abamectin results in increased expression of STAT3 mRNA] |
CTD |
PMID:34748272 |
|
NCBI chr10:85,811,206...85,863,057
Ensembl chr10:85,811,218...85,863,057
|
|
G |
Tnf |
tumor necrosis factor |
increases expression multiple interactions |
EXP |
abamectin results in increased expression of TNF mRNA; abamectin results in increased expression of TNF protein [Ascorbic Acid co-treated with Sesame Oil] inhibits the reaction [abamectin results in increased expression of TNF protein]; Ascorbic Acid inhibits the reaction [abamectin results in increased expression of TNF protein]; Hesperidin inhibits the reaction [abamectin results in increased expression of TNF mRNA]; Sesame Oil inhibits the reaction [abamectin results in increased expression of TNF protein] |
CTD |
PMID:31739238 PMID:34748272 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|
G |
Tubb3 |
tubulin, beta 3 class III |
decreases expression |
ISO |
abamectin results in decreased expression of TUBB3 protein |
CTD |
PMID:19879343 |
|
NCBI chr19:51,457,187...51,466,243
Ensembl chr19:51,457,184...51,466,243
|
|
|
G |
Aatf |
apoptosis antagonizing transcription factor |
decreases expression |
ISO |
beauvericin results in decreased expression of AATF mRNA |
CTD |
PMID:29203277 |
|
NCBI chr10:69,299,029...69,392,207
Ensembl chr10:69,299,037...69,392,201
|
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of ABCA1 mRNA |
CTD |
PMID:31100301 |
|
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
|
|
G |
Abcg1 |
ATP binding cassette subfamily G member 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of ABCG1 mRNA |
CTD |
PMID:31100301 |
|
NCBI chr20:9,126,687...9,182,948
Ensembl chr20:9,126,687...9,182,948
|
|
G |
Acat2 |
acetyl-CoA acetyltransferase 2 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of ACAT2 protein |
CTD |
PMID:32407736 |
|
NCBI chr 1:47,695,833...47,713,879
Ensembl chr 1:47,695,788...47,752,821
|
|
G |
Acin1 |
apoptotic chromatin condensation inducer 1 |
decreases expression |
ISO |
beauvericin results in decreased expression of ACIN1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr15:28,102,112...28,147,001
Ensembl chr15:28,102,112...28,147,001
|
|
G |
Acsl4 |
acyl-CoA synthetase long-chain family member 4 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of ACSL4 protein |
CTD |
PMID:32407736 |
|
NCBI chr X:105,942,794...106,006,573
Ensembl chr X:105,942,799...106,006,427
|
|
G |
Actb |
actin, beta |
decreases expression |
ISO |
beauvericin results in decreased expression of ACTB mRNA |
CTD |
PMID:29203277 |
|
NCBI chr12:11,663,112...11,666,697
Ensembl chr12:11,663,109...11,672,877
|
|
G |
Aen |
apoptosis enhancing nuclease |
decreases expression |
ISO |
beauvericin results in decreased expression of AEN mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 1:132,815,094...132,824,522
Ensembl chr 1:132,815,142...132,824,523
|
|
G |
Aifm1 |
apoptosis inducing factor, mitochondria associated 1 |
decreases expression |
ISO |
beauvericin results in decreased expression of AIFM1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr X:127,650,223...127,689,356
Ensembl chr X:127,650,226...127,689,256
|
|
G |
Ak4 |
adenylate kinase 4 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of AK4 mRNA |
CTD |
PMID:31100301 |
|
NCBI chr 5:116,039,222...116,099,064
Ensembl chr 5:116,039,616...116,098,618
|
|
G |
Aldh5a1 |
aldehyde dehydrogenase 5 family, member A1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of ALDH5A1 protein |
CTD |
PMID:32407736 |
|
NCBI chr17:40,132,339...40,158,677
Ensembl chr17:40,130,883...40,158,677
|
|
G |
Aldoa |
aldolase, fructose-bisphosphate A |
decreases expression |
ISO |
beauvericin results in decreased expression of ALDOA mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 1:181,402,275...181,407,476
Ensembl chr 1:181,402,275...181,406,182
|
|
G |
Anapc13 |
anaphase promoting complex subunit 13 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of ANAPC13 protein |
CTD |
PMID:32407736 |
|
NCBI chr 8:103,205,520...103,213,936
Ensembl chr 8:103,205,520...103,213,936
|
|
G |
Aprt |
adenine phosphoribosyl transferase |
decreases expression |
ISO |
beauvericin results in decreased expression of APRT mRNA |
CTD |
PMID:29203277 |
|
NCBI chr19:50,626,436...50,628,404
Ensembl chr19:50,626,202...50,628,431
|
|
G |
Ar |
androgen receptor |
multiple interactions |
ISO |
beauvericin inhibits the reaction [Dihydrotestosterone results in increased expression of AR mRNA] |
CTD |
PMID:30716354 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Arhgdia |
Rho GDP dissociation inhibitor alpha |
decreases expression |
ISO |
beauvericin results in decreased expression of ARHGDIA mRNA |
CTD |
PMID:29203277 |
|
NCBI chr10:105,854,526...105,858,020
Ensembl chr10:105,854,533...105,858,023
|
|
G |
Arpp21 |
cAMP regulated phosphoprotein 21 |
increases expression |
ISO |
beauvericin results in increased expression of ARPP21 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 8:112,034,636...112,199,273
Ensembl chr 8:112,034,642...112,194,297
|
|
G |
Atp1a1 |
ATPase Na+/K+ transporting subunit alpha 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of ATP1A1 protein |
CTD |
PMID:32407736 |
|
NCBI chr 2:189,020,722...189,048,826
Ensembl chr 2:189,020,722...189,048,837
|
|
G |
Atp1a3 |
ATPase Na+/K+ transporting subunit alpha 3 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of ATP1A3 protein |
CTD |
PMID:32407736 |
|
NCBI chr 1:80,572,790...80,601,936
Ensembl chr 1:80,572,796...80,601,918
|
|
G |
Atp5pb |
ATP synthase peripheral stalk-membrane subunit b |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of ATP5PB protein |
CTD |
PMID:32407736 |
|
NCBI chr 2:193,424,138...193,435,418
Ensembl chr 2:193,424,047...193,435,418
|
|
G |
Atp5pf |
ATP synthase peripheral stalk subunit F6 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of ATP5PF protein |
CTD |
PMID:32407736 |
|
NCBI chr11:23,881,594...23,889,581
Ensembl chr11:23,881,592...23,889,119
|
|
G |
Bax |
BCL2 associated X, apoptosis regulator |
decreases expression multiple interactions |
ISO |
beauvericin results in decreased expression of BAX mRNA [zearalenol co-treated with beauvericin] results in increased expression of BAX mRNA |
CTD |
PMID:29203277 PMID:32956828 |
|
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
|
|
G |
Bcl2 |
BCL2, apoptosis regulator |
increases expression multiple interactions |
ISO |
beauvericin results in increased expression of BCL2 mRNA [zearalenol co-treated with beauvericin] results in increased expression of BCL2 mRNA |
CTD |
PMID:29203277 PMID:32956828 |
|
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
|
|
G |
Birc2 |
baculoviral IAP repeat-containing 2 |
increases expression |
ISO |
beauvericin results in increased expression of BIRC2 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 8:4,968,856...4,989,325
Ensembl chr 8:4,968,842...4,988,732
|
|
G |
Birc3 |
baculoviral IAP repeat-containing 3 |
increases expression |
ISO |
beauvericin results in increased expression of BIRC3 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 8:5,000,844...5,028,470
Ensembl chr 8:5,000,845...5,015,802
|
|
G |
Btf3l4 |
basic transcription factor 3-like 4 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of BTF3L4 protein |
CTD |
PMID:32407736 |
|
NCBI chr 5:123,569,059...123,587,593
Ensembl chr 5:123,567,907...123,586,866
|
|
G |
C1qtnf3 |
C1q and TNF related 3 |
decreases expression |
ISO |
beauvericin results in decreased expression of C1QTNF3 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 2:59,917,099...59,939,519
Ensembl chr 2:59,917,188...59,939,433
|
|
G |
C1qtnf6 |
C1q and TNF related 6 |
increases expression |
ISO |
beauvericin results in increased expression of C1QTNF6 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 7:110,077,867...110,084,584
Ensembl chr 7:110,077,878...110,084,412
|
|
G |
Caap1 |
caspase activity and apoptosis inhibitor 1 |
decreases expression |
ISO |
beauvericin results in decreased expression of CAAP1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 5:109,313,253...109,414,323
Ensembl chr 5:109,361,912...109,414,314
|
|
G |
Card11 |
caspase recruitment domain family, member 11 |
decreases expression |
ISO |
beauvericin results in decreased expression of CARD11 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr12:13,620,979...13,758,115
Ensembl chr12:13,621,087...13,758,112
|
|
G |
Casp3 |
caspase 3 |
increases activity multiple interactions |
EXP ISO |
beauvericin results in increased activity of CASP3 protein [zearalenol co-treated with beauvericin] results in increased expression of CASP3 mRNA |
CTD |
PMID:25178661 PMID:32956828 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Casp7 |
caspase 7 |
increases activity |
EXP |
beauvericin results in increased activity of CASP7 protein |
CTD |
PMID:25178661 |
|
NCBI chr 1:255,437,195...255,476,737
Ensembl chr 1:255,437,172...255,476,729
|
|
G |
Casp8 |
caspase 8 |
increases expression |
ISO |
beauvericin results in increased expression of CASP8 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 9:60,263,863...60,312,542
Ensembl chr 9:60,264,075...60,312,542
|
|
G |
Casp9 |
caspase 9 |
increases expression |
ISO |
beauvericin results in increased expression of CASP9 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
|
|
G |
Ccar2 |
cell cycle and apoptosis regulator 2 |
decreases expression |
ISO |
beauvericin results in decreased expression of CCAR2 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr15:45,212,797...45,228,001
Ensembl chr15:45,212,803...45,227,636
|
|
G |
Ccdc124 |
coiled-coil domain containing 124 |
decreases expression |
ISO |
beauvericin results in decreased expression of CCDC124 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr16:18,566,745...18,572,564
Ensembl chr16:18,566,745...18,572,564
|
|
G |
Ccdc180 |
coiled-coil domain containing 180 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of CCDC180 protein |
CTD |
PMID:32407736 |
|
NCBI chr 5:60,154,883...60,223,508
Ensembl chr 5:60,154,910...60,223,522
|
|
G |
Ccdc86 |
coiled-coil domain containing 86 |
decreases expression |
ISO |
beauvericin results in decreased expression of CCDC86 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 1:207,590,946...207,596,527
Ensembl chr 1:207,590,168...207,596,544
|
|
G |
Ccng2 |
cyclin G2 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of CCNG2 mRNA |
CTD |
PMID:31100301 |
|
NCBI chr14:14,804,321...14,812,819
Ensembl chr14:14,804,322...14,812,830
|
|
G |
Cct5 |
chaperonin containing TCP1 subunit 5 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of CCT5 protein |
CTD |
PMID:32407736 |
|
NCBI chr 2:82,591,750...82,602,903
Ensembl chr 2:82,590,630...82,602,930
|
|
G |
Cd47 |
Cd47 molecule |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of CD47 protein |
CTD |
PMID:32407736 |
|
NCBI chr11:50,906,052...50,970,000
Ensembl chr11:50,906,177...50,969,425
|
|
G |
Cd81 |
Cd81 molecule |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of CD81 protein |
CTD |
PMID:32407736 |
|
NCBI chr 1:198,235,861...198,251,660
Ensembl chr 1:198,241,484...198,251,660
|
|
G |
Cdk2ap2 |
cyclin-dependent kinase 2 associated protein 2 |
decreases expression |
ISO |
beauvericin results in decreased expression of CDK2AP2 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 1:201,391,056...201,393,137
Ensembl chr 1:201,391,466...201,393,137
|
|
G |
Cebpb |
CCAAT/enhancer binding protein beta |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of CEBPB mRNA |
CTD |
PMID:31100301 |
|
NCBI chr 3:156,398,035...156,399,466
Ensembl chr 3:156,397,052...156,399,473
|
|
G |
Cflar |
CASP8 and FADD-like apoptosis regulator |
increases expression |
ISO |
beauvericin results in increased expression of CFLAR mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 9:60,185,338...60,236,173
Ensembl chr 9:60,185,452...60,237,034
|
|
G |
Chchd2 |
coiled-coil-helix-coiled-coil-helix domain containing 2 |
decreases expression |
ISO |
beauvericin results in decreased expression of CHCHD2 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr12:26,828,738...26,834,762
Ensembl chr12:26,828,736...26,834,755
|
|
G |
Ciapin1 |
cytokine induced apoptosis inhibitor 1 |
decreases expression |
ISO |
beauvericin results in decreased expression of CIAPIN1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr19:10,179,963...10,195,511
Ensembl chr19:10,180,100...10,195,503
|
|
G |
Cnp |
2',3'-cyclic nucleotide 3' phosphodiesterase |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of CNP protein |
CTD |
PMID:32407736 |
|
NCBI chr10:85,511,164...85,517,723
Ensembl chr10:85,511,160...85,517,720
|
|
G |
Coa6 |
cytochrome c oxidase assembly factor 6 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of COA6 protein |
CTD |
PMID:32407736 |
|
NCBI chr19:54,395,682...54,398,918
Ensembl chr19:54,395,742...54,399,407
|
|
G |
Coro1c |
coronin 1C |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of CORO1C protein |
CTD |
PMID:32407736 |
|
NCBI chr12:42,712,960...42,785,179
Ensembl chr12:42,712,991...42,785,179
|
|
G |
Cotl1 |
coactosin-like F-actin binding protein 1 |
decreases expression |
ISO |
beauvericin results in decreased expression of COTL1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr19:47,871,689...47,906,010
Ensembl chr19:47,871,694...47,911,689
|
|
G |
Cplane2 |
ciliogenesis and planar polarity effector complex subunit 2 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of CPLANE2 protein |
CTD |
PMID:32407736 |
|
NCBI chr 5:153,515,507...153,516,455
Ensembl chr 5:153,515,376...153,522,508
|
|
G |
Cpne1 |
copine 1 |
decreases expression |
ISO |
beauvericin results in decreased expression of CPNE1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 3:144,587,548...144,629,603
Ensembl chr 3:144,588,995...144,598,636
|
|
G |
Crim1 |
cysteine rich transmembrane BMP regulator 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of CRIM1 mRNA |
CTD |
PMID:31100301 |
|
NCBI chr 6:16,695,864...16,870,264
Ensembl chr 6:16,697,829...16,870,259
|
|
G |
Csdc2 |
cold shock domain containing C2 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of CSDC2 protein |
CTD |
PMID:32407736 |
|
NCBI chr 7:113,451,998...113,466,464
Ensembl chr 7:113,451,998...113,466,463
|
|
G |
Csk |
C-terminal Src kinase |
decreases expression |
ISO |
beauvericin results in decreased expression of CSK mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 8:58,029,748...58,048,742
Ensembl chr 8:58,029,749...58,048,292
|
|
G |
Ctps1 |
CTP synthase 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of CTPS1 protein |
CTD |
PMID:32407736 |
|
NCBI chr 5:134,125,022...134,154,155
Ensembl chr 5:134,125,025...134,154,180
|
|
G |
Ctsd |
cathepsin D |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of CTSD protein |
CTD |
PMID:32407736 |
|
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
|
|
G |
Cyp4f39 |
cytochrome P450, family 4, subfamily f, polypeptide 39 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of CYP4F22 protein |
CTD |
PMID:32407736 |
|
NCBI chr 7:11,426,806...11,505,553
Ensembl chr 7:11,433,371...11,536,181
|
|
G |
Dcxr |
dicarbonyl and L-xylulose reductase |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of DCXR protein |
CTD |
PMID:32407736 |
|
NCBI chr10:106,006,404...106,008,294
|
|
G |
Ddias |
DNA damage-induced apoptosis suppressor |
decreases expression |
ISO |
beauvericin results in decreased expression of DDIAS mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 1:146,906,150...146,930,462
Ensembl chr 1:146,906,154...146,930,462
|
|
G |
Ddx47 |
DEAD-box helicase 47 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of DDX47 protein |
CTD |
PMID:32407736 |
|
NCBI chr 4:167,845,652...167,858,115
Ensembl chr 4:167,845,640...167,859,115
|
|
G |
Dhrs7 |
dehydrogenase/reductase 7 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of DHRS7 protein |
CTD |
PMID:32407736 |
|
NCBI chr 6:91,332,259...91,347,856
Ensembl chr 6:91,251,323...91,347,892
|
|
G |
Edem1 |
ER degradation enhancing alpha-mannosidase like protein 1 |
increases expression |
ISO |
beauvericin results in increased expression of EDEM1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 4:141,797,631...141,829,717
Ensembl chr 4:141,797,701...141,829,717
|
|
G |
Eif5a |
eukaryotic translation initiation factor 5A |
decreases expression |
ISO |
beauvericin results in decreased expression of EIF5A mRNA |
CTD |
PMID:29203277 |
|
NCBI chr10:54,640,104...54,644,845
Ensembl chr10:54,640,024...54,644,656
|
|
G |
Faim2 |
Fas apoptotic inhibitory molecule 2 |
increases expression |
ISO |
beauvericin results in increased expression of FAIM2 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 7:130,632,368...130,659,353
Ensembl chr 7:130,633,348...130,659,168
|
|
G |
Fmc1 |
formation of mitochondrial complex V assembly factor 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of FMC1 protein |
CTD |
PMID:32407736 |
|
NCBI chr 4:67,274,104...67,282,140
Ensembl chr 4:67,274,104...67,282,140
|
|
G |
Gaa |
alpha glucosidase |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of GAA protein |
CTD |
PMID:32407736 |
|
NCBI chr10:104,529,673...104,546,836
Ensembl chr10:104,529,747...104,546,836
|
|
G |
Gna14 |
G protein subunit alpha 14 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of GNA14 protein |
CTD |
PMID:32407736 |
|
NCBI chr 1:213,714,993...213,900,083
Ensembl chr 1:213,716,020...213,897,423
|
|
G |
Gnai3 |
G protein subunit alpha i3 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of GNAI3 protein |
CTD |
PMID:32407736 |
|
NCBI chr 2:195,742,765...195,780,720
Ensembl chr 2:195,742,642...195,780,742
|
|
G |
Gnb1 |
G protein subunit beta 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of GNB1 protein |
CTD |
PMID:32407736 |
|
NCBI chr 5:166,075,508...166,142,223
Ensembl chr 5:166,075,629...166,142,124
|
|
G |
Golga1 |
golgin A1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of GOLGA1 protein |
CTD |
PMID:32407736 |
|
NCBI chr 3:22,765,690...22,812,637
Ensembl chr 3:22,767,761...22,812,585
|
|
G |
Gpnmb |
glycoprotein nmb |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of GPNMB protein |
CTD |
PMID:32407736 |
|
NCBI chr 4:78,010,247...78,031,491
Ensembl chr 4:78,010,197...78,049,367
|
|
G |
Gpr18 |
G protein-coupled receptor 18 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of GPR18 mRNA |
CTD |
PMID:31100301 |
|
NCBI chr15:98,997,427...99,001,177
Ensembl chr15:98,997,259...99,001,470
|
|
G |
Hexb |
hexosaminidase subunit beta |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of HEXB protein |
CTD |
PMID:32407736 |
|
NCBI chr 2:28,483,997...28,504,165
Ensembl chr 2:28,484,012...28,504,223
|
|
G |
Hist2h2be |
histone cluster 2 H2B family member E |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of HIST2H2BE protein |
CTD |
PMID:32407736 |
|
NCBI chr 2:183,780,449...183,783,030
|
|
G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of HMGCS1 mRNA |
CTD |
PMID:31100301 |
|
NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100
|
|
G |
Hnrnpm |
heterogeneous nuclear ribonucleoprotein M |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of HNRNPM protein |
CTD |
PMID:32407736 |
|
NCBI chr 7:14,438,703...14,476,781
Ensembl chr 7:14,438,688...14,476,762
|
|
G |
Hnrnpu |
heterogeneous nuclear ribonucleoprotein U |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of HNRNPU protein |
CTD |
PMID:32407736 |
|
NCBI chr13:90,069,058...90,086,905
Ensembl chr13:90,074,181...90,086,588
|
|
G |
Hspa5 |
heat shock protein family A (Hsp70) member 5 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of HSPA5 mRNA |
CTD |
PMID:31100301 |
|
NCBI chr 3:18,055,507...18,059,969
Ensembl chr 3:18,055,405...18,059,891
|
|
G |
Immt |
inner membrane mitochondrial protein |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of IMMT protein |
CTD |
PMID:32407736 |
|
NCBI chr 4:103,880,482...103,919,116
Ensembl chr 4:103,880,459...103,919,109
|
|
G |
Insig1 |
insulin induced gene 1 |
increases expression |
ISO |
beauvericin results in increased expression of INSIG1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 4:7,315,494...7,323,972
Ensembl chr 4:7,315,495...7,323,952
|
|
G |
Islr2 |
immunoglobulin superfamily containing leucine-rich repeat 2 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of ISLR2 protein |
CTD |
PMID:32407736 |
|
NCBI chr 8:58,608,165...58,616,246
Ensembl chr 8:58,608,709...58,614,650
|
|
G |
Itgb1 |
integrin subunit beta 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of ITGB1 protein |
CTD |
PMID:32407736 |
|
NCBI chr19:56,705,123...56,753,199
Ensembl chr19:56,705,171...56,753,195
|
|
G |
Klf12 |
KLF transcription factor 12 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of KLF12 protein |
CTD |
PMID:32407736 |
|
NCBI chr15:76,628,778...77,062,000
Ensembl chr15:76,637,654...77,062,056
|
|
G |
Kpnb1 |
karyopherin subunit beta 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of KPNB1 protein |
CTD |
PMID:32407736 |
|
NCBI chr10:82,145,662...82,174,437
Ensembl chr10:82,145,420...82,174,605
|
|
G |
Krt16 |
keratin 16 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of KRT16 protein |
CTD |
PMID:32407736 |
|
NCBI chr10:85,168,357...85,171,744
Ensembl chr10:85,066,802...85,171,799
|
|
G |
Krt27 |
keratin 27 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of KRT27 protein |
CTD |
PMID:32407736 |
|
NCBI chr10:84,298,684...84,303,967
Ensembl chr10:84,298,508...84,303,967
|
|
G |
Krt5 |
keratin 5 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of KRT5 protein |
CTD |
PMID:32407736 |
|
NCBI chr 7:132,846,355...132,851,986
Ensembl chr 7:132,846,136...132,851,850
|
|
G |
Krt76 |
keratin 76 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of KRT76 protein |
CTD |
PMID:32407736 |
|
NCBI chr 7:133,016,990...133,025,414
Ensembl chr 7:133,016,992...133,025,496
|
|
G |
Lamp2 |
lysosomal-associated membrane protein 2 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of LAMP2 protein |
CTD |
PMID:32407736 |
|
NCBI chr X:117,173,097...117,222,090
Ensembl chr X:117,057,606...117,260,522
|
|
G |
Lat |
linker for activation of T cells |
decreases expression |
ISO |
beauvericin results in decreased expression of LAT mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 1:180,936,536...180,941,561
Ensembl chr 1:180,936,534...180,941,578
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
decreases phosphorylation |
EXP |
beauvericin results in decreased phosphorylation of MAPK1 protein |
CTD |
PMID:25178661 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
decreases phosphorylation |
EXP |
beauvericin results in decreased phosphorylation of MAPK3 protein |
CTD |
PMID:25178661 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Matn4 |
matrilin 4 |
decreases expression |
ISO |
beauvericin results in decreased expression of MATN4 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 3:153,120,605...153,135,628
Ensembl chr 3:153,120,632...153,135,865
|
|
G |
Mavs |
mitochondrial antiviral signaling protein |
increases expression |
ISO |
beauvericin results in increased expression of MAVS mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 3:118,451,650...118,466,094
Ensembl chr 3:118,451,743...118,466,094
|
|
G |
Med6 |
mediator complex subunit 6 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of MED6 protein |
CTD |
PMID:32407736 |
|
NCBI chr 6:101,270,410...101,283,929
Ensembl chr 6:101,270,410...101,283,876
|
|
G |
Moap1 |
modulator of apoptosis 1 |
increases expression |
ISO |
beauvericin results in increased expression of MOAP1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 6:121,882,565...121,884,500
Ensembl chr 6:121,882,366...121,898,643
|
|
G |
Mrpl12 |
mitochondrial ribosomal protein L12 |
decreases expression multiple interactions |
ISO |
beauvericin results in decreased expression of MRPL12 mRNA [beauvericin co-treated with enniatins] results in decreased expression of MRPL12 mRNA |
CTD |
PMID:29203277 PMID:31100301 |
|
NCBI chr10:105,758,410...105,762,913
Ensembl chr10:105,758,410...105,762,913
|
|
G |
Mrpl4 |
mitochondrial ribosomal protein L4 |
decreases expression |
ISO |
beauvericin results in decreased expression of MRPL4 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 8:19,539,593...19,545,608
Ensembl chr 8:19,539,593...19,545,608
|
|
G |
Mt-atp6 |
mitochondrially encoded ATP synthase membrane subunit 6 |
decreases expression multiple interactions |
ISO |
beauvericin results in decreased expression of ATP6 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of ATP6 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of ATP6 mRNA; [beauvericin co-treated with enniatins] results in increased expression of ATP6 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in decreased expression of ATP6 mRNA; [Plant Extracts co-treated with beauvericin] results in decreased expression of ATP6 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in decreased expression of ATP6 mRNA |
CTD |
PMID:29203277 PMID:31100301 PMID:34015425 |
|
NCBI chr MT:7,919...8,599
Ensembl chr MT:7,919...8,599
|
|
G |
Mt-atp8 |
mitochondrially encoded ATP synthase membrane subunit 8 |
decreases expression multiple interactions |
ISO |
beauvericin results in decreased expression of ATP8 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of ATP8 mRNA; [beauvericin co-treated with enniatins] affects the expression of ATP8 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of ATP8 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in decreased expression of ATP8 mRNA; [Plant Extracts co-treated with beauvericin] results in decreased expression of ATP8 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in decreased expression of ATP8 mRNA |
CTD |
PMID:29203277 PMID:31100301 PMID:34015425 |
|
NCBI chr MT:7,758...7,961
Ensembl chr MT:7,758...7,961
|
|
G |
Mt-co1 |
mitochondrially encoded cytochrome c oxidase I |
multiple interactions decreases expression |
ISO |
[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of COX1 mRNA; [beauvericin co-treated with enniatins] affects the expression of COX1 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of COX1 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in decreased expression of COX1 mRNA; [Plant Extracts co-treated with beauvericin] results in decreased expression of COX1 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in decreased expression of COX1 mRNA beauvericin results in decreased expression of COX1 mRNA |
CTD |
PMID:31100301 PMID:34015425 |
|
NCBI chr MT:5,323...6,867
Ensembl chr MT:5,323...6,867
|
|
G |
Mt-co3 |
mitochondrially encoded cytochrome c oxidase III |
decreases expression multiple interactions |
ISO |
beauvericin results in decreased expression of COX3 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of COX3 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of COX3 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in decreased expression of COX3 mRNA; [Plant Extracts co-treated with beauvericin] results in decreased expression of COX3 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in decreased expression of COX3 mRNA |
CTD |
PMID:29203277 PMID:31100301 PMID:34015425 |
|
NCBI chr MT:8,599...9,382
Ensembl chr MT:8,599...9,382
|
|
G |
Mt-cyb |
mitochondrially encoded cytochrome b |
decreases expression |
ISO |
beauvericin results in decreased expression of CYTB mRNA |
CTD |
PMID:29203277 |
|
NCBI chr MT:14,136...15,278
Ensembl chr MT:14,136...15,278
|
|
G |
Mt-nd2 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2 |
decreases expression increases expression multiple interactions |
ISO |
beauvericin results in decreased expression of ND2 mRNA beauvericin results in increased expression of ND2 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of ND2 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of ND2 mRNA; [beauvericin co-treated with enniatins] results in increased expression of ND2 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of ND2 mRNA; [Plant Extracts co-treated with beauvericin] results in increased expression of ND2 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in increased expression of ND2 mRNA |
CTD |
PMID:29203277 PMID:31100301 PMID:34015425 |
|
NCBI chr MT:3,904...4,942
Ensembl chr MT:3,904...4,942
|
|
G |
Mt-nd3 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3 |
decreases expression increases expression multiple interactions |
ISO |
beauvericin results in decreased expression of ND3 mRNA beauvericin results in increased expression of ND3 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of ND3 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of ND3 mRNA; [beauvericin co-treated with enniatins] results in increased expression of ND3 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of ND3 mRNA; [Plant Extracts co-treated with beauvericin] results in increased expression of ND3 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in increased expression of ND3 mRNA |
CTD |
PMID:29203277 PMID:31100301 PMID:34015425 |
|
NCBI chr MT:9,451...9,798
Ensembl chr MT:9,451...9,798
|
|
G |
Mt-nd4 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4 |
decreases expression multiple interactions |
ISO |
beauvericin results in decreased expression of ND4 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of ND4 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of ND4 mRNA; [beauvericin co-treated with enniatins] results in increased expression of ND4 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of ND4 mRNA; [Plant Extracts co-treated with beauvericin] results in increased expression of ND4 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in decreased expression of ND4 mRNA |
CTD |
PMID:29203277 PMID:31100301 PMID:34015425 |
|
NCBI chr MT:10,160...11,537
Ensembl chr MT:10,160...11,537
|
|
G |
Mt-nd4l |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L |
decreases expression increases expression multiple interactions |
ISO |
beauvericin results in decreased expression of ND4L mRNA beauvericin results in increased expression of ND4L mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of ND4L mRNA; [beauvericin co-treated with enniatins] results in decreased expression of ND4L mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of ND4L mRNA; [Plant Extracts co-treated with beauvericin] results in increased expression of ND4L mRNA |
CTD |
PMID:29203277 PMID:31100301 PMID:34015425 |
|
NCBI chr MT:9,870...10,166
Ensembl chr MT:9,870...10,166
|
|
G |
Mt-nd5 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5 |
decreases expression increases expression multiple interactions |
ISO |
beauvericin results in decreased expression of ND5 mRNA beauvericin results in increased expression of ND5 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of ND5 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of ND5 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of ND5 mRNA; [Plant Extracts co-treated with beauvericin] results in increased expression of ND5 mRNA |
CTD |
PMID:29203277 PMID:31100301 PMID:34015425 |
|
NCBI chr MT:11,736...13,565
Ensembl chr MT:11,736...13,565
|
|
G |
Mt-nd6 |
mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6 |
decreases expression multiple interactions |
ISO |
beauvericin results in decreased expression of ND6 mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of ND6 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of ND6 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of ND6 mRNA; [Plant Extracts co-treated with beauvericin] results in increased expression of ND6 mRNA |
CTD |
PMID:34015425 |
|
NCBI chr MT:13,543...14,061
Ensembl chr MT:13,543...14,061
|
|
G |
Mtrf1l |
mitochondrial translation release factor 1 like |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of MTRF1L protein |
CTD |
PMID:32407736 |
|
NCBI chr 1:42,208,553...42,221,020
Ensembl chr 1:42,210,583...42,220,836
|
|
G |
Myo18a |
myosin XVIIIa |
increases expression |
ISO |
beauvericin results in increased expression of MYO18A mRNA |
CTD |
PMID:29203277 |
|
NCBI chr10:62,654,218...62,755,464
Ensembl chr10:62,654,281...62,755,468
|
|
G |
Nars1 |
asparaginyl-tRNA synthetase 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of NARS1 protein |
CTD |
PMID:32407736 |
|
NCBI chr18:57,989,308...58,005,639
Ensembl chr18:57,989,308...58,005,622
|
|
G |
Nars2 |
asparaginyl-tRNA synthetase 2, mitochondrial |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of NARS2 protein |
CTD |
PMID:32407736 |
|
NCBI chr 1:151,300,446...151,412,069
Ensembl chr 1:151,300,467...151,413,521
|
|
G |
Ndrg1 |
N-myc downstream regulated 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of NDRG1 protein |
CTD |
PMID:32407736 |
|
NCBI chr 7:98,684,487...98,725,869
Ensembl chr 7:98,684,487...98,725,880
|
|
G |
Nlrp1a |
NLR family, pyrin domain containing 1A |
increases expression |
ISO |
beauvericin results in increased expression of NLRP1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr10:55,778,560...55,833,639
Ensembl chr10:55,778,560...55,825,180
|
|
G |
Nod1 |
nucleotide-binding oligomerization domain containing 1 |
increases expression |
ISO |
beauvericin results in increased expression of NOD1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 4:84,060,871...84,111,668
Ensembl chr 4:84,060,880...84,111,404
|
|
G |
Nol3 |
nucleolar protein 3 |
increases expression |
ISO |
beauvericin results in increased expression of NOL3 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr19:33,154,061...33,158,250
Ensembl chr19:33,154,062...33,158,250
|
|
G |
Nqo1 |
NAD(P)H quinone dehydrogenase 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of NQO1 mRNA |
CTD |
PMID:31100301 |
|
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
|
|
G |
Nudt1 |
nudix hydrolase 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of NUDT1 protein |
CTD |
PMID:32407736 |
|
NCBI chr12:14,302,514...14,309,559
Ensembl chr12:14,302,694...14,305,826
|
|
G |
Oga |
O-GlcNAcase |
increases expression |
ISO |
beauvericin results in increased expression of OGA mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 1:244,598,285...244,633,835
Ensembl chr 1:244,598,292...244,634,359
|
|
G |
Ogt |
O-linked N-acetylglucosamine (GlcNAc) transferase |
increases expression |
ISO |
beauvericin results in increased expression of OGT mRNA |
CTD |
PMID:29203277 |
|
NCBI chr X:66,771,278...66,816,148
Ensembl chr X:66,771,349...66,816,146
|
|
G |
Osgin1 |
oxidative stress induced growth inhibitor 1 |
multiple interactions increases expression |
ISO |
[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of OSGIN1 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of OSGIN1 mRNA; [Plant Extracts co-treated with beauvericin] results in increased expression of OSGIN1 mRNA beauvericin results in increased expression of OSGIN1 mRNA |
CTD |
PMID:31100301 PMID:34015425 |
|
NCBI chr19:47,471,750...47,500,517
Ensembl chr19:47,492,171...47,500,516
|
|
G |
Ostc |
oligosaccharyltransferase complex non-catalytic subunit |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of OSTC protein |
CTD |
PMID:32407736 |
|
NCBI chr 2:219,250,549...219,266,076
Ensembl chr 2:219,236,952...219,266,107
|
|
G |
Parvg |
parvin, gamma |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of PARVG protein |
CTD |
PMID:32407736 |
|
NCBI chr 7:115,456,183...115,475,707
Ensembl chr 7:115,456,209...115,475,104
|
|
G |
Pawr |
pro-apoptotic WT1 regulator |
decreases expression |
ISO |
beauvericin results in decreased expression of PAWR mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 7:43,645,028...43,725,033
Ensembl chr 7:43,645,084...43,725,028
|
|
G |
Pdcd11 |
programmed cell death 11 |
decreases expression |
ISO |
beauvericin results in decreased expression of PDCD11 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 1:245,980,840...246,021,999
Ensembl chr 1:245,980,880...246,021,999
|
|
G |
Pdcd2 |
programmed cell death 2 |
decreases expression |
ISO |
beauvericin results in decreased expression of PDCD2 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 1:56,484,947...56,490,437
Ensembl chr 1:56,463,931...56,490,437
|
|
G |
Pdcd2l |
programmed cell death 2-like |
increases expression |
ISO |
beauvericin results in increased expression of PDCD2L mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 1:86,810,292...86,822,554
Ensembl chr 1:86,810,292...86,822,554
|
|
G |
Pdcd4 |
programmed cell death 4 |
decreases expression |
ISO |
beauvericin results in decreased expression of PDCD4 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 1:252,921,342...252,944,278
Ensembl chr 1:252,921,392...252,944,275
|
|
G |
Pdcd5 |
programmed cell death 5 |
increases expression |
ISO |
beauvericin results in increased expression of PDCD5 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 1:88,305,869...88,311,200
Ensembl chr 1:88,305,869...88,311,200
|
|
G |
Pdcd6ip |
programmed cell death 6 interacting protein |
increases expression |
ISO |
beauvericin results in increased expression of PDCD6IP mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 8:113,590,998...113,646,795
Ensembl chr 8:113,590,998...113,646,773
|
|
G |
Pdia4 |
protein disulfide isomerase family A, member 4 |
decreases expression |
ISO |
beauvericin results in decreased expression of PDIA4 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 4:76,803,198...76,822,245
Ensembl chr 4:76,803,198...76,822,107
|
|
G |
Pfn1 |
profilin 1 |
decreases expression multiple interactions |
ISO |
beauvericin results in decreased expression of PFN1 mRNA [beauvericin co-treated with enniatins] results in increased expression of PFN1 protein |
CTD |
PMID:29203277 PMID:32407736 |
|
NCBI chr10:55,365,263...55,367,968
Ensembl chr10:55,365,262...55,527,631
|
|
G |
Pgam1 |
phosphoglycerate mutase 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of PGAM1 protein |
CTD |
PMID:32407736 |
|
NCBI chr 1:240,723,832...240,731,443
Ensembl chr 1:240,723,920...240,738,452
|
|
G |
Pgk1 |
phosphoglycerate kinase 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of PGK1 protein |
CTD |
PMID:32407736 |
|
NCBI chr X:71,271,454...71,287,429
Ensembl chr X:71,271,440...71,287,418
|
|
G |
Phgdh |
phosphoglycerate dehydrogenase |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of PHGDH protein |
CTD |
PMID:32407736 |
|
NCBI chr 2:185,906,964...185,936,160
Ensembl chr 2:185,906,966...185,935,944
|
|
G |
Phka2 |
phosphorylase kinase regulatory subunit alpha 2 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of PHKA2 protein |
CTD |
PMID:32407736 |
|
NCBI chr X:34,170,959...34,293,498
Ensembl chr X:34,171,323...34,293,466
|
|
G |
Pidd1 |
p53-induced death domain protein 1 |
decreases expression |
ISO |
beauvericin results in decreased expression of PIDD1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 1:196,536,815...196,542,808
Ensembl chr 1:196,536,834...196,542,699
|
|
G |
Plk1 |
polo-like kinase 1 |
decreases expression |
ISO |
beauvericin results in decreased expression of PLK1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 1:176,716,420...176,726,400
Ensembl chr 1:176,716,420...176,726,400
|
|
G |
Pls3 |
plastin 3 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of PLS3 protein |
CTD |
PMID:32407736 |
|
NCBI chr X:111,589,193...111,683,908
Ensembl chr X:111,589,254...111,683,891
|
|
G |
Ppa1 |
inorganic pyrophosphatase 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of PPA1 protein |
CTD |
PMID:32407736 |
|
NCBI chr20:29,590,733...29,617,711
Ensembl chr20:29,590,707...29,619,215
|
|
G |
Ppan |
peter pan homolog |
decreases expression |
ISO |
beauvericin results in decreased expression of PPAN mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 8:19,423,908...19,427,941
Ensembl chr 8:19,423,961...19,427,938
|
|
G |
Ppib |
peptidylprolyl isomerase B |
decreases expression |
ISO |
beauvericin results in decreased expression of PPIB mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 8:66,603,877...66,609,734
Ensembl chr 8:66,603,861...66,630,428
|
|
G |
Ppp1r14b |
protein phosphatase 1, regulatory (inhibitor) subunit 14B |
decreases expression |
ISO |
beauvericin results in decreased expression of PPP1R14B mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 1:204,165,210...204,167,320
Ensembl chr 1:204,163,299...204,167,319
|
|
G |
Ppt1 |
palmitoyl-protein thioesterase 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of PPT1 protein |
CTD |
PMID:32407736 |
|
NCBI chr 5:135,121,176...135,141,076
Ensembl chr 5:135,121,163...135,142,048
|
|
G |
Prkca |
protein kinase C, alpha |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of PRKCA protein |
CTD |
PMID:32407736 |
|
NCBI chr10:92,889,390...93,288,013
Ensembl chr10:92,894,012...93,288,012
|
|
G |
Psma5 |
proteasome 20S subunit alpha 5 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of PSMA5 protein |
CTD |
PMID:32407736 |
|
NCBI chr 2:195,896,369...195,919,733
Ensembl chr 2:195,896,365...195,919,731
|
|
G |
Psme4 |
proteasome activator subunit 4 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of PSME4 protein |
CTD |
PMID:32407736 |
|
NCBI chr14:104,505,716...104,609,410
Ensembl chr14:104,505,716...104,609,408
|
|
G |
Ptges3 |
prostaglandin E synthase 3 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of PTGES3 protein |
CTD |
PMID:32407736 |
|
NCBI chr 7:490,698...507,759
Ensembl chr 7:490,656...508,084
|
|
G |
Ptprc |
protein tyrosine phosphatase, receptor type, C |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of PTPRC protein |
CTD |
PMID:32407736 |
|
NCBI chr13:49,596,193...49,708,283
Ensembl chr13:49,596,193...49,708,692
|
|
G |
Rab11fip5 |
RAB11 family interacting protein 5 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of RAB11FIP5 protein |
CTD |
PMID:32407736 |
|
NCBI chr 4:117,871,301...117,908,819
Ensembl chr 4:117,871,308...117,908,741
|
|
G |
Rab5a |
RAB5A, member RAS oncogene family |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of RAB5A protein |
CTD |
PMID:32407736 |
|
NCBI chr 9:6,483,906...6,512,877
Ensembl chr 9:6,484,469...6,512,873
|
|
G |
Rac3 |
Rac family small GTPase 3 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of RAC3 protein |
CTD |
PMID:32407736 |
|
NCBI chr10:106,002,808...106,005,244
Ensembl chr10:105,993,087...106,005,260
|
|
G |
Rap1a |
RAP1A, member of RAS oncogene family |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of RAP1A protein |
CTD |
PMID:32407736 |
|
NCBI chr 2:193,208,631...193,286,513
Ensembl chr 2:193,208,635...193,286,501
|
|
G |
Relt |
RELT, TNF receptor |
decreases expression |
ISO |
beauvericin results in decreased expression of RELT mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 1:155,206,976...155,224,609
Ensembl chr 1:155,206,976...155,214,196
|
|
G |
Rp2 |
RP2 activator of ARL3 GTPase |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of RP2 protein |
CTD |
PMID:32407736 |
|
NCBI chr X:1,872,581...1,916,704
Ensembl chr X:1,873,306...1,916,688
|
|
G |
Rpl37a |
ribosomal protein L37A |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of RPL37A protein |
CTD |
PMID:32407736 |
|
NCBI chr 9:74,298,861...74,300,926
|
|
G |
Rpl5 |
ribosomal protein L5 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of RPL5 protein |
CTD |
PMID:32407736 |
|
NCBI chr14:1,843,856...1,850,301
Ensembl chr14:1,843,770...1,850,290
|
|
G |
Rpl8 |
ribosomal protein L8 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of RPL8 protein |
CTD |
PMID:32407736 |
|
NCBI chr 7:108,626,194...108,628,485
Ensembl chr 7:108,622,324...108,628,482
|
|
G |
Rxra |
retinoid X receptor alpha |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of RXRA protein |
CTD |
PMID:32407736 |
|
NCBI chr 3:10,989,832...11,076,366
Ensembl chr 3:10,989,832...11,073,712
|
|
G |
Scml2 |
Scm polycomb group protein like 2 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of SCML2 protein |
CTD |
PMID:32407736 |
|
NCBI chr X:33,523,179...33,677,672
Ensembl chr X:33,524,530...33,652,742
|
|
G |
Sdf2l1 |
stromal cell-derived factor 2-like 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of SDF2L1 protein |
CTD |
PMID:32407736 |
|
NCBI chr11:83,872,659...83,874,902
Ensembl chr11:83,872,659...83,874,902
|
|
G |
Sdr42e2 |
short chain dehydrogenase/reductase family 42E, member 2 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of SDR42E2 protein |
CTD |
PMID:32407736 |
|
NCBI chr 1:175,361,630...175,382,769
Ensembl chr 1:175,362,150...175,382,050
|
|
G |
Sec13 |
SEC13 homolog, nuclear pore and COPII coat complex component |
decreases expression |
ISO |
beauvericin results in decreased expression of SEC13 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 4:146,877,739...146,891,130
Ensembl chr 4:146,875,524...146,891,173
|
|
G |
Siva1 |
SIVA1, apoptosis-inducing factor |
decreases expression |
ISO |
beauvericin results in decreased expression of SIVA1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 6:131,705,312...131,709,697
Ensembl chr 6:131,705,323...131,709,690
|
|
G |
Slc1a5 |
solute carrier family 1 member 5 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of SLC1A5 protein |
CTD |
PMID:32407736 |
|
NCBI chr 1:77,456,849...77,470,952
Ensembl chr 1:77,456,694...77,470,952
|
|
G |
Slc2a1 |
solute carrier family 2 member 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of SLC2A1 protein |
CTD |
PMID:32407736 |
|
NCBI chr 5:132,717,196...132,745,416
Ensembl chr 5:132,717,196...132,745,416
|
|
G |
Slc3a2 |
solute carrier family 3 member 2 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of SLC3A2 protein |
CTD |
PMID:32407736 |
|
NCBI chr 1:205,604,468...205,618,931
Ensembl chr 1:205,604,468...205,618,931
|
|
G |
Snrpd2 |
small nuclear ribonucleoprotein D2 polypeptide |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of SNRPD2 protein |
CTD |
PMID:32407736 |
|
NCBI chr 1:78,798,377...78,801,227
Ensembl chr 1:78,798,377...78,803,351
|
|
G |
Snrpd3 |
small nuclear ribonucleoprotein D3 polypeptide |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of SNRPD3 protein |
CTD |
PMID:32407736 |
|
NCBI chr20:13,130,112...13,145,947
Ensembl chr20:13,130,119...13,145,978
|
|
G |
Src |
SRC proto-oncogene, non-receptor tyrosine kinase |
decreases activity |
EXP |
beauvericin results in decreased activity of SRC protein |
CTD |
PMID:25178661 |
|
NCBI chr 3:146,091,969...146,139,492
Ensembl chr 3:146,091,841...146,139,476
|
|
G |
Srm |
spermidine synthase |
decreases expression |
ISO |
beauvericin results in decreased expression of SRM mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 5:159,025,919...159,029,076
Ensembl chr 5:159,025,873...159,029,405
|
|
G |
Srsf7 |
serine and arginine rich splicing factor 7 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of SRSF7 protein |
CTD |
PMID:32407736 |
|
NCBI chr 6:14,811,775...14,818,968
Ensembl chr 6:14,811,808...14,818,965
|
|
G |
Srxn1 |
sulfiredoxin 1 |
multiple interactions decreases expression |
ISO |
[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in decreased expression of SRXN1 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of SRXN1 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in decreased expression of SRXN1 mRNA; [Plant Extracts co-treated with beauvericin] results in decreased expression of SRXN1 mRNA beauvericin results in decreased expression of SRXN1 mRNA |
CTD |
PMID:31100301 PMID:34015425 |
|
NCBI chr 3:140,604,490...140,610,050
Ensembl chr 3:140,599,608...140,628,448
|
|
G |
Ssbp1 |
single stranded DNA binding protein 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of SSBP1 protein |
CTD |
PMID:32407736 |
|
NCBI chr 4:69,266,024...69,276,135
Ensembl chr 4:69,266,102...69,276,135
|
|
G |
Tbc1d2b |
TBC1 domain family, member 2B |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of TBC1D2B protein |
CTD |
PMID:32407736 |
|
NCBI chr 8:90,746,220...90,814,867
Ensembl chr 8:90,746,233...90,814,832
|
|
G |
Tcn2 |
transcobalamin 2 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of TCN2 protein |
CTD |
PMID:32407736 |
|
NCBI chr14:78,813,343...78,828,549
Ensembl chr14:78,813,343...78,828,489
|
|
G |
Tcp11l1 |
t-complex 11 like 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of TCP11L1 protein |
CTD |
PMID:32407736 |
|
NCBI chr 3:91,047,006...91,092,687
Ensembl chr 3:90,998,270...91,092,006
|
|
G |
Tcp11l2 |
t-complex 11 like 2 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of TCP11L2 protein |
CTD |
PMID:32407736 |
|
NCBI chr 7:19,150,241...19,185,135
Ensembl chr 7:19,150,252...19,185,095
|
|
G |
Thyn1 |
thymocyte nuclear protein 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of THYN1 protein |
CTD |
PMID:32407736 |
|
NCBI chr 8:25,406,563...25,415,444
Ensembl chr 8:25,406,500...25,415,445
|
|
G |
Timm9 |
translocase of inner mitochondrial membrane 9 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of TIMM9 protein |
CTD |
PMID:32407736 |
|
NCBI chr 6:89,610,094...89,622,924
Ensembl chr 6:89,610,094...89,622,924
|
|
G |
Tk1 |
thymidine kinase 1 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of TK1 protein |
CTD |
PMID:32407736 |
|
NCBI chr10:103,034,755...103,046,125
Ensembl chr10:103,031,521...103,046,920
|
|
G |
Tmem263 |
transmembrane protein 263 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of TMEM263 protein |
CTD |
PMID:32407736 |
|
NCBI chr 7:18,607,077...18,628,436
Ensembl chr 7:18,610,149...18,628,534
|
|
G |
Tnfsf10 |
TNF superfamily member 10 |
decreases expression |
ISO |
beauvericin results in decreased expression of TNFSF10 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 2:110,199,835...110,227,239
Ensembl chr 2:110,207,916...110,225,135
|
|
G |
Tomm22 |
translocase of outer mitochondrial membrane 22 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of TOMM22 protein |
CTD |
PMID:32407736 |
|
NCBI chr 7:111,223,508...111,228,671
Ensembl chr 7:111,216,571...111,246,799
|
|
G |
Tomm7 |
translocase of outer mitochondrial membrane 7 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of TOMM7 protein |
CTD |
PMID:32407736 |
|
NCBI chr 4:11,305,122...11,311,963
Ensembl chr 4:11,305,110...11,311,962
|
|
G |
Tuba1b |
tubulin, alpha 1B |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of TUBA1B protein |
CTD |
PMID:32407736 |
|
NCBI chr 7:130,090,669...130,093,644
Ensembl chr 7:130,081,032...130,196,186
|
|
G |
Tubb3 |
tubulin, beta 3 class III |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of TUBB3 protein |
CTD |
PMID:32407736 |
|
NCBI chr19:51,457,187...51,466,243
Ensembl chr19:51,457,184...51,466,243
|
|
G |
Tubb4a |
tubulin, beta 4A class IVa |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of TUBB4A protein |
CTD |
PMID:32407736 |
|
NCBI chr 9:1,917,841...1,925,286
Ensembl chr 9:1,917,845...1,925,291
|
|
G |
Tubb4b |
tubulin, beta 4B class IVb |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of TUBB4B protein |
CTD |
PMID:32407736 |
|
NCBI chr 3:8,037,844...8,040,294
Ensembl chr 3:8,037,799...8,040,296
|
|
G |
Tubb5 |
tubulin, beta 5 class I |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of TUBB protein |
CTD |
PMID:32407736 |
|
NCBI chr20:2,912,779...2,916,928
Ensembl chr20:2,912,778...2,916,940
|
|
G |
Txnip |
thioredoxin interacting protein |
increases expression multiple interactions decreases expression |
ISO |
beauvericin results in increased expression of TXNIP mRNA [beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of TXNIP mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of TXNIP mRNA; [Plant Extracts co-treated with beauvericin] results in increased expression of TXNIP mRNA beauvericin results in decreased expression of TXNIP mRNA |
CTD |
PMID:29203277 PMID:34015425 |
|
NCBI chr 2:184,093,079...184,096,882
Ensembl chr 2:184,092,991...184,096,886
|
|
G |
Ucp2 |
uncoupling protein 2 |
multiple interactions decreases expression |
ISO |
[beauvericin co-treated with enniatins co-treated with ochratoxin A] results in increased expression of UCP2 mRNA; [beauvericin co-treated with enniatins] results in decreased expression of UCP2 mRNA; [Plant Extracts co-treated with beauvericin co-treated with enniatins] results in increased expression of UCP2 mRNA; [Plant Extracts co-treated with beauvericin] results in increased expression of UCP2 mRNA; [Plant Extracts co-treated with ochratoxin A co-treated with Zearalenone co-treated with beauvericin] results in decreased expression of UCP2 mRNA beauvericin results in decreased expression of UCP2 mRNA |
CTD |
PMID:31100301 PMID:34015425 |
|
NCBI chr 1:154,839,242...154,845,612
Ensembl chr 1:154,839,209...154,845,611
|
|
G |
Ucp3 |
uncoupling protein 3 |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in decreased expression of UCP3 mRNA |
CTD |
PMID:31100301 |
|
NCBI chr 1:154,815,777...154,828,764
Ensembl chr 1:154,815,777...154,828,762
|
|
G |
Ybx1 |
Y box binding protein 1 |
decreases expression |
ISO |
beauvericin results in decreased expression of YBX1 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 5:132,882,137...132,899,108
Ensembl chr 5:132,882,145...132,898,862
|
|
G |
Ybx3 |
Y box binding protein 3 |
decreases expression |
ISO |
beauvericin results in decreased expression of YBX3 mRNA |
CTD |
PMID:29203277 |
|
NCBI chr 4:165,129,747...165,153,101
Ensembl chr 4:165,129,758...165,153,161
|
|
G |
Ykt6 |
YKT6 v-SNARE homolog |
multiple interactions |
ISO |
[beauvericin co-treated with enniatins] results in increased expression of YKT6 protein |
CTD |
PMID:32407736 |
|
NCBI chr14:80,832,187...80,843,394
Ensembl chr14:80,832,187...80,843,385
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
decreases activity multiple interactions |
ISO |
emamectin results in decreased activity of ABCB1 protein emamectin inhibits the reaction [ABCB1 protein results in increased transport of bisbenzimide ethoxide trihydrochloride] emamectin results in decreased activity of ABCB1A protein emamectin inhibits the reaction [ABCB1A protein results in increased transport of bisbenzimide ethoxide trihydrochloride] |
CTD |
PMID:25865432 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Abcc1 |
ATP binding cassette subfamily C member 1 |
multiple interactions decreases activity |
ISO |
emamectin inhibits the reaction [ABCC1 protein results in increased transport of bisbenzimide ethoxide trihydrochloride] emamectin results in decreased activity of ABCC1 protein |
CTD |
PMID:25865432 |
|
NCBI chr10:528,961...655,179
Ensembl chr10:531,812...655,114
|
|
G |
Ncoa2 |
nuclear receptor coactivator 2 |
multiple interactions |
ISO |
emamectin inhibits the reaction [Chenodeoxycholic Acid promotes the reaction [NCOA2 protein modified form binds to NR1H4 protein]] |
CTD |
PMID:27773686 |
|
NCBI chr 5:5,835,642...6,069,693
Ensembl chr 5:5,835,706...6,067,451
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
multiple interactions |
ISO |
emamectin inhibits the reaction [Chenodeoxycholic Acid promotes the reaction [NCOA2 protein modified form binds to NR1H4 protein]]; emamectin inhibits the reaction [Chenodeoxycholic Acid results in increased activity of NR1H4 protein]; emamectin inhibits the reaction [pregna-4,17-diene-3,16-dione results in decreased activity of NR1H4 protein] |
CTD |
PMID:25257666 PMID:27773686 |
|
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
|
|
|
G |
Cat |
catalase |
multiple interactions decreases activity |
ISO |
Plant Oils inhibits the reaction [emamectin benzoate results in decreased activity of CAT protein] |
CTD |
PMID:29268245 |
|
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions increases expression |
ISO |
Plant Oils inhibits the reaction [emamectin benzoate results in increased expression of CYP2E1 mRNA] |
CTD |
PMID:29268245 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Dio1 |
iodothyronine deiodinase 1 |
decreases activity |
ISO |
emamectin benzoate results in decreased activity of DIO1 protein |
CTD |
PMID:29228274 |
|
NCBI chr 5:122,074,285...122,090,983
Ensembl chr 5:122,074,279...122,090,970
|
|
G |
Mgst1 |
microsomal glutathione S-transferase 1 |
increases expression multiple interactions |
ISO |
emamectin benzoate results in increased expression of MGST1 mRNA Plant Oils inhibits the reaction [emamectin benzoate results in increased expression of MGST1 mRNA] |
CTD |
PMID:29268245 |
|
NCBI chr 4:171,029,666...171,044,893
Ensembl chr 4:171,029,630...171,044,892
|
|
G |
Nts |
neurotensin |
affects activity |
ISO |
emamectin benzoate affects the activity of NTS protein |
CTD |
PMID:23611293 |
|
NCBI chr 7:37,564,944...37,574,350
Ensembl chr 7:37,564,533...37,574,423
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
decreases activity |
ISO |
eprinomectin results in decreased activity of ABCB1A protein |
CTD |
PMID:17134887 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Ano1 |
anoctamin 1 |
decreases activity |
ISO |
eprinomectin results in decreased activity of ANO1 protein |
CTD |
PMID:32201246 |
|
NCBI chr 1:199,751,439...199,900,099
Ensembl chr 1:199,751,439...199,900,069
|
|
G |
Ncoa2 |
nuclear receptor coactivator 2 |
multiple interactions |
ISO |
eprinomectin inhibits the reaction [Chenodeoxycholic Acid promotes the reaction [NCOA2 protein modified form binds to NR1H4 protein]] |
CTD |
PMID:27773686 |
|
NCBI chr 5:5,835,642...6,069,693
Ensembl chr 5:5,835,706...6,067,451
|
|
G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
multiple interactions |
ISO |
eprinomectin inhibits the reaction [Chenodeoxycholic Acid promotes the reaction [NCOA2 protein modified form binds to NR1H4 protein]] |
CTD |
PMID:27773686 |
|
NCBI chr 7:23,846,122...23,942,085
Ensembl chr 7:23,846,122...23,942,047
|
|
|
G |
Abcb1a |
ATP binding cassette subfamily B member 1A |
multiple interactions decreases activity |
ISO |
spinosad inhibits the reaction [ABCB1 protein results in increased transport of calcein AM]; spinosad inhibits the reaction [ABCB1 protein results in increased transport of Digoxin]; spinosad inhibits the reaction [ABCB1 protein results in increased transport of Ivermectin] spinosad results in decreased activity of ABCB1 protein |
CTD |
PMID:21321059 |
|
NCBI chr 4:25,357,467...25,529,941
Ensembl chr 4:25,158,362...25,442,709
|
|
G |
Chrna7 |
cholinergic receptor nicotinic alpha 7 subunit |
decreases response to substance |
ISO |
CHRNA7 protein mutant form results in decreased susceptibility to spinosad |
CTD |
PMID:23016960 |
|
NCBI chr 1:116,715,286...116,837,223
Ensembl chr 1:116,714,711...116,837,240
|
|